These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31233276)

  • 1. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
    Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
    Zhang X; Wang G; Bi Y; Jiang Z; Wang X
    Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells.
    Kono M; Yoshida N; Maeda K; Tsokos GC
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):2478-2483. PubMed ID: 29463741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microRNA-448 suppresses CD4
    Zhang J; Guo Y; Sun Y; Chang L; Wang X
    Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.
    Zhao M; Tan Y; Peng Q; Huang C; Guo Y; Liang G; Zhu B; Huang Y; Liu A; Wang Z; Li M; Gao X; Wu R; Wu H; Long H; Lu Q
    Nat Commun; 2018 Feb; 9(1):583. PubMed ID: 29422534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists.
    Miao Y; Zheng Y; Geng Y; Yang L; Cao N; Dai Y; Wei Z
    Theranostics; 2021; 11(9):4531-4548. PubMed ID: 33754076
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.
    Kono M; Yoshida N; Maeda K; Skinner NE; Pan W; Kyttaris VC; Tsokos MG; Tsokos GC
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9288-9293. PubMed ID: 30150402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro silencing of RIP2 in naive CD4
    Song ZC; Liu ST; Xia XY; Hu JJ; Leng RX; Zhao W
    Clin Rheumatol; 2024 Nov; 43(11):3515-3523. PubMed ID: 39235498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
    Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC
    J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
    Cheng T; Ding S; Liu S; Li X; Tang X; Sun L
    Front Immunol; 2021; 12():668760. PubMed ID: 34093566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren's Syndrome.
    Fu J; Pu Y; Wang B; Li H; Yang X; Xie L; Shi H; Wang Z; Yin J; Zhan T; Shao Y; Chen C; Luo Q; Xu J; Zong Z; Wei X; Xiao W; Yu C; Zheng L
    J Immunol Res; 2022; 2022():3210200. PubMed ID: 35211629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate.
    Wu B; Liu J; Zhao R; Li Y; Peer J; Braun AL; Zhao L; Wang Y; Tong Z; Huang Y; Zheng JC
    J Neuroinflammation; 2018 Mar; 15(1):79. PubMed ID: 29540215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cellular metabolism to reduce head and neck cancer growth.
    Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X
    Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.
    McDonald CJ; Acheff E; Kennedy R; Taylor L; Curthoys NP
    Neurochem Int; 2015 Sep; 88():10-4. PubMed ID: 25510640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors.
    Shukla K; Ferraris DV; Thomas AG; Stathis M; Duvall B; Delahanty G; Alt J; Rais R; Rojas C; Gao P; Xiang Y; Dang CV; Slusher BS; Tsukamoto T
    J Med Chem; 2012 Dec; 55(23):10551-63. PubMed ID: 23151085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.
    Elgogary A; Xu Q; Poore B; Alt J; Zimmermann SC; Zhao L; Fu J; Chen B; Xia S; Liu Y; Neisser M; Nguyen C; Lee R; Park JK; Reyes J; Hartung T; Rojas C; Rais R; Tsukamoto T; Semenza GL; Hanes J; Slusher BS; Le A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):E5328-36. PubMed ID: 27559084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1.
    Li J; Zuo L; Tian Y; He Y; Zhang Z; Guo P; Ge Y; Hu J
    J Cell Mol Med; 2019 Aug; 23(8):5632-5641. PubMed ID: 31211512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.